EMPYREAN THERAPEUTICS LTD
Company number 11372447 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£867,357
Balance sheet as at 2021-11-30
What it does
The principal activity of the company is medical research.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2018-05-21
- Employees
- 5 (2024 accounts · was 6 in 2023)
- Registered office
- Building 250 Babraham Research Campus, Babraham, Cambridge, England, CB22 3AT
- Postcode
- CB22 3AT
- Capital
- 1 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2024-11-30
- Next due by
- 2026-08-31
- Financial year end
- 30 November
Confirmation statement
- Last statement dated
- 2026-02-25
- Next due by
- 2027-03-11
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 1 current
Group structure
Controlled by CAMBRIDGE PRIME LTD — since 2020-07-07
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Data protection registration
Registered with the ICO as a data protection fee payer — ZB864387 (Tier 1), registered since 2025.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Previous registered addresses 2
| Address | Changed on |
|---|---|
| BUILDING 250 BUILDING 250, BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CAMBRIDGESHIRE, CB22 3AT, UNITED KINGDOM | 2020-09-16 |
| 75 CYPRIAN RUST WAY, SOHAM, ELY, CB7 5ZE, UNITED KINGDOM | 2018-07-11 |
Competitors Cambridge
This company ranks 59 among research and experimental development on biotechnology in Cambridge.
The class of 2018
36%
of the 439 companies in this sector incorporated in 2018 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.